These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Outcome and prognostic factors in ocular adnexal lymphoma. Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428 [TBL] [Abstract][Full Text] [Related]
4. Prognostic factors for relapse and survival among patients with ocular adnexal lymphoma: validation of the eighth edition of the American Joint Committee on Cancer (AJCC) TNM classification. Kwon M; Lee JS; Lee C; Yoon DH; Sa HS Br J Ophthalmol; 2021 Feb; 105(2):279-284. PubMed ID: 32327417 [TBL] [Abstract][Full Text] [Related]
5. Ocular adnexal lymphoma staging and treatment: American Joint Committee on Cancer versus Ann Arbor. Graue GF; Finger PT; Maher E; Della Rocca D; Della Rocca R; Lelli GJ; Milman T Eur J Ophthalmol; 2013; 23(3):344-55. PubMed ID: 23397158 [TBL] [Abstract][Full Text] [Related]
6. Comparison of American Joint Committee on Cancer TNM-based staging system (7th edition) and Ann Arbor classification for predicting outcome in ocular adnexal lymphoma. Rath S; Connors JM; Dolman PJ; Rootman J; Rootman DB; White VA Orbit; 2014 Feb; 33(1):23-8. PubMed ID: 24180616 [TBL] [Abstract][Full Text] [Related]
7. Clinical features associated with survival of patients with lymphoma of the ocular adnexa. Jenkins C; Rose GE; Bunce C; Cree I; Norton A; Plowman PN; Moseley I; Wright JE Eye (Lond); 2003 Oct; 17(7):809-20. PubMed ID: 14528242 [TBL] [Abstract][Full Text] [Related]
8. Specific location of ocular adnexal lymphoma and mortality: an international multicentre retrospective study. Vest SD; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Hindso TG; Holm F; Honavar SG; Khong JJ; Kirkegaard MK; McKelvie PA; Mikkelsen LH; Mulay K; Rasmussen PK; Siersma V; Sjö LD; Sniegowski MC; Thuro BA; Vemuganti GK; Heegaard S Br J Ophthalmol; 2023 Sep; 107(9):1231-1238. PubMed ID: 35512851 [TBL] [Abstract][Full Text] [Related]
9. Ocular adnexal lymphoma: validation of American Joint Committee on Cancer seventh edition staging guidelines. Sniegowski MC; Roberts D; Bakhoum M; Mc Laughlin P; Yin VT; Turturro F; Esmaeli B Br J Ophthalmol; 2014 Sep; 98(9):1255-60. PubMed ID: 24759874 [TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic analysis of ocular adnexal lymphomas: extranodal marginal zone b-cell lymphoma constitutes the vast majority of ocular lymphomas among Koreans and affects younger patients. Cho EY; Han JJ; Ree HJ; Ko YH; Kang YK; Ahn HS; Ahn SD; Park CJ; Huh J Am J Hematol; 2003 Jun; 73(2):87-96. PubMed ID: 12749009 [TBL] [Abstract][Full Text] [Related]
12. Association of T and N Categories of the American Joint Commission on Cancer, 8th Edition, With Metastasis and Survival in Patients With Orbital Sarcoma. Sa HS; Rubin ML; Ning J; Li W; Tetzlaff MT; McGovern SL; Paulino AC; Herzog CE; Gill JB; Esmaeli B JAMA Ophthalmol; 2020 Apr; 138(4):374-381. PubMed ID: 32105303 [TBL] [Abstract][Full Text] [Related]
13. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems. Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542 [TBL] [Abstract][Full Text] [Related]
14. Prognosis for patients in a Korean population with ocular adnexal lymphoproliferative lesions. Yoon JS; Ma KT; Kim SJ; Kook K; Lee SY Ophthalmic Plast Reconstr Surg; 2007; 23(2):94-9. PubMed ID: 17413620 [TBL] [Abstract][Full Text] [Related]
15. Feasibility of the TNM-based staging system of ocular adnexal extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). Lee SE; Paik JS; Cho WK; Choi BO; Lee SN; Jung SE; Park KS; Kang CS; Kim SH; Yang SW; Cho SG Am J Hematol; 2011 Mar; 86(3):262-6. PubMed ID: 21328439 [TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics of 95 patients with ocular adnexal and uveal lymphoma: treatment outcomes in extranodal marginal zone subtype. Portell CA; Aronow ME; Rybicki LA; Macklis R; Singh AD; Sweetenham JW Clin Lymphoma Myeloma Leuk; 2014 Jun; 14(3):203-10. PubMed ID: 24417911 [TBL] [Abstract][Full Text] [Related]
17. Diffuse large B-cell lymphoma of the ocular adnexal region: a nation-based study. Rasmussen PK; Ralfkiaer E; Prause JU; Sjö LD; Toft PB; Siersma VD; Heegaard S Acta Ophthalmol; 2013 Mar; 91(2):163-9. PubMed ID: 22551232 [TBL] [Abstract][Full Text] [Related]
18. Radiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa: a multiinstitutional, retrospective review of 50 patients. Uno T; Isobe K; Shikama N; Nishikawa A; Oguchi M; Ueno N; Itami J; Ohnishi H; Mikata A; Ito H Cancer; 2003 Aug; 98(4):865-71. PubMed ID: 12910532 [TBL] [Abstract][Full Text] [Related]
19. Clinicopathological Features of Ocular Adnexal Mantle-Cell Lymphoma in an International Multicenter Cohort. Knudsen MKH; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Khong JJ; McKelvie PA; Mulay K; Ralfkiaer E; Sjö LD; Vemuganti GK; Thuro BA; Curtin J; Heegaard S JAMA Ophthalmol; 2017 Dec; 135(12):1367-1374. PubMed ID: 29121219 [TBL] [Abstract][Full Text] [Related]
20. Squamous carcinoma and dysplasia of the conjunctiva and cornea: an analysis of 101 cases. Yousef YA; Finger PT Ophthalmology; 2012 Feb; 119(2):233-40. PubMed ID: 22189448 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]